Skip to main content

PNEUMONIA- Its Etiology, Pathophysiology, Classification and Severity Assessment Method!

 PNEUMONIA

Definition:

"Pneumonia is an infection of pulmonary parenchyma". (Harrison)

                                                   OR

"Pneumonia is defined as an acute respiratory illness associated with recently developed radiological pulmonary shadowing which may be segmental, lobar or multilobar". (Davidson)



Etiology:

  • Microorganisms gain excess to the lower respiratory tract in several ways:

  1. Aspiration from the oropharynx (most common).
  2. Inhalation of contaminated droplets.
  3. Hematogenous spread.
  4. Contiguous extension.

Pathophysiology of Pneumonia:

  • Pneumonia results from proliferation of microbial pathogens at the alveolar level and the hosts response to these microorganisms. 


Defensive Mechanisms against Pneumonia:

  • The defensive mechanism against pneumonia involve:

  1. Branching architecture of tracheobronchial tree.
  2. Muco-ciliary clearance.
  3. Local antibacterial factors.
  4. Gag Reflex.
  5. Cough mechanism.
  6. Normal flora adhering to mucosal cells of oropharynx.
  7. Alveolar macrophages, local proteins

  • The alveolar macrophages initiate the inflammatory response to strengthen the lower respiratory tract defenses.

IL-1 & TNF (Tumor necrosis factor) -- Fever

IL-8 release and attraction of neutrophil to lungs -- Peripheral leukocytosis.

Inflammatory mediators (Macrophages and Neutrophils) -- Localized alveolar capillary leak


Stages of Pneumonia:

  1. Oedematous phase:

  • Alveoli filled with proteinaceous exudate and bacteria.
  • Rapidly followed by red hepatization phase

      2. Stage of Red Hepatization:

  • Presence of erythrocytes (RBC) in the cellular interalveolar exudate.
  • Neutrophil influx.
  • Bacteria can be seen in specimens.

      3. Stage of Grey Hepatization:

  • Erythrocyte extravasation (leakage) ceases.
  • Neutrophil predominant.
  • Abundant fibrin deposition.
  • Disappearance of bacteria.

      4. Stage of Resolution:

  • Macrophages reappear.
  • Debris cleared.
  • Inflammatory response cleared.


Clinical Features:

  1. Fever
  2. Rigors
  3. Shivering
  4. Delirium
  5. Headache
  6. Cough with sputum 
  7. Rust colored sputum in patients with S.pneumoniae
  8. Pleuritic chest pain
  9. Respiratory and pulse rate raised.
  10. Lower Blood pressure

Classification:

  • Pneumonia was typically classified as:

  1. Community-Acquired Pneumonia (CAP)
  2. Hospital-Acquired Pneumonia (HAP)
  3. Ventilator-Associated Pneumonia (VAP)

  • Over the past few decades, however some persons presenting as outpatients with onset of pneumonia have been found to be infected with Multi0drug resistant pathogens previously associated with HAP; thus, development of the term Healthcare-Associated Pneumonia (HCAP).


  • Classification on the Basis of Anatomy:

  1. Lobar Pneumonia
  2. Interstitial Pneumonia
  3. Broncho Pneumonia

  • Classification On the Basis of Etiology/Causes:

  1. Primary Pneumonia
  2. Secondary Pneumonia (including Aspiration pneumonia)
  3. Suppurative Pneumonia (Necrotizing Pneumonia)

  • Classification on the Basis of Mode of Acquiring Pneumonia:

  1. CAP
  2. HAP/ VAP
  3. HCAP
  4. Pneumonia in Immuno-compromised host


*Information Notes*

*Lobar Pneumonia: is a radiological and pathological term (involves lobe of the lung); referring to homogenous consolidation of one or more lung lobes with associated pleural inflammation.

Bronchopneumonia refers to more patchy alveolar consolidation associated with bronchial or bronchiolar inflammation often affecting both lower limbs (affects lungs along with bronchi).

Organisms responsible for Primary Pneumonia include Bacteria ( S.pneumoniae. H.influenza, Staphylococcus aureus, Pseudomonas aeruginosa) and Viruses (Adenovirus, Influenza virus, coronavirus, SARS associated coronavirus, Measles, Herpes Simples virus) *


Severity Assessment:

CURB-65

  • Confusion
  • Urea >7mmol/L
  • Respiratory rate > 30/min
  • Blood Pressure (systolic <90mmHg and Diastolic <60mmHg
  • Age > 65years

Score 1 point for each feature!




Comments

Popular posts from this blog

General Mechanism of Actions of INSULIN.

GENERAL MECHANISM OF ACTION OF INSULIN AND RELATE HORMONES The body's main fuel is Glucose. Glucose is stored in the liver and muscles as Glycogen.  Excess glucose is stored in the adipose tissues which yield fatty acids via lipolysis. In the fasting state, free fatty acids supply much of the energy needs of the body except for the CNS which requires Glucose to function normally. Proteins can also be converted to glucose via gluconeogenesis. RELEASE OF INSULIN AND GLUCAGON Insulin and Glucagon are produced in the pancreas by the Islets of Langerhans . Beta cells   make up 70%-90% of the Islets and produce Insulin and Amylin while the a-cells   produce glucagon. The main function of insulin is to decrease blood glucose levels. Glucagon, along with other counter-regulatory hormones such as growth factor, cortisol, and Epinephrine, increases Blood glucose levels.  The opposing actions of Glucagon and Insulin along with other counter-regulatory hormones maintain a norma...

Diabetes Mellitus: Its Goals Of Therapy!

  GOAL OF THERPY The goals of treatment of DM includes; Reducing, controlling and managing long-term microvascular, macrovascular and neuropaathic complications. Preserving beta cell function. Preventing acute complications from increased Blood glucosel level. Minimizing hypoglycemic episodes. Maintaining patient quality of life. --Two landmark trials, THE DIABETES CONTROL AND COMPLICATION TRIAL (DCCT) and THE UNITED KINGDOM PROSPECTIVE DIABETES STUDY(UKPDS), showed that lowering blood glucose levels decreased the risk of developing chronic complications. --A near normal blood glucose level can be achieved with appropriate patient education , lifestyle modification and medications . --Proper care of DM requires goal setting and assessment for glycemic control , self-monitoring of blood glucose (SMBG) monitoring of blood glucose pressure , and lipid levels , regular monitoring for the development of complications , dietary and exercise lifestyle modifications and proper medicatio...

Diabetes Mellitus: Clinical Presentation and Diagnosis!

 CLINICAL PRESENTATION AND DIAGNOSIS OF DM 2. SCREENING American Diabetes Association (ADA) recommends routine screening for T2 DM every 3 years in all adults starting at 45 years of age. Testing of T2 DM should be considered in any adult, regardless of their age, who have a BMI greater than or equal to 25kg/m2. The ADA does not currently recommend widespread screening for T1 DM because of the relatively low incidence in the general population, although measurement of Islet antibodies may be appropriate for high-risk individuals. 3.GESTATIONAL DIABETES: "Gestational diabetes is the glucose intolerance in women during pregnancy". All pregnant women who have risk factors for T2 DM should be screened for undiagnosed T2 DM at their first prenatal visit using standard diagnostic criteria.  Any women found to have diabetes in the early point at pregnancy is considered to have T2 DM or GDM. All other pregnant women, not currently known to have DM should be screened for GDM with a 75...